CLS Q1: A solid quarter largely in line with our expectations - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

CLS Q1: A solid quarter largely in line with our expectations - Redeye

{newsItem.title}

Redeye provides an update following CLS’s Q1 2025 report. Sales during the quarter amounted to SEK4.5m, and the company showed solid cost control. The quarterly figures aligned well with our expectations, and we only made minor adjustments to our estimates in this update, leaving our fair value range untouched.

Länk till analysen i sin helhet: https://www.redeye.se/research/1109759/cls-q1-a-solid-quarter-largely-in-line-with-our-expectations?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt